Balyasny Asset Management’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-56,165
| Closed | -$169K | – | 2215 |
|
|
2025
Q1 | $169K | Buy |
+56,165
| New | +$169K | ﹤0.01% | 1846 |
|
|
2024
Q4 | – | Sell |
-65,811
| Closed | -$245K | – | 2129 |
|
|
2024
Q3 | $245K | Sell |
65,811
-141,385
| -68% | -$526K | ﹤0.01% | 1744 |
|
|
2024
Q2 | $1.31M | Buy |
+207,196
| New | +$1.31M | ﹤0.01% | 1172 |
|
|
2023
Q3 | – | Sell |
-193,285
| Closed | -$537K | – | 1969 |
|
|
2023
Q2 | $537K | Buy |
193,285
+121,019
| +167% | +$336K | ﹤0.01% | 1446 |
|
|
2023
Q1 | $132K | Sell |
72,266
-824,695
| -92% | -$1.5M | ﹤0.01% | 1853 |
|
|
2022
Q4 | $4.55M | Buy |
896,961
+849,054
| +1,772% | +$4.3M | 0.01% | 797 |
|
|
2022
Q3 | $238K | Sell |
47,907
-17,038
| -26% | -$84.6K | ﹤0.01% | 1788 |
|
|
2022
Q2 | $242K | Buy |
+64,945
| New | +$242K | ﹤0.01% | 1725 |
|
|
2018
Q2 | – | Sell |
-11,189
| Closed | -$44K | – | 1735 |
|
|
2018
Q1 | $44K | Buy |
+11,189
| New | +$44K | ﹤0.01% | 1674 |
|
|
2017
Q3 | – | Sell |
-50,000
| Closed | -$380K | – | 1735 |
|
|
2017
Q2 | $380K | Buy |
+50,000
| New | +$380K | ﹤0.01% | 1072 |
|